
Sign up to save your podcasts
Or
The biotech company, Valneva announced this month about the promising work and progress on two vaccine candidates--the mosquito borne virus, chikungunya and Lyme disease.
On today's show I am joined by Valneva President and CEO, Thomas Lingelbach to discuss the latest on these vaccine candidates.
4.4
1717 ratings
The biotech company, Valneva announced this month about the promising work and progress on two vaccine candidates--the mosquito borne virus, chikungunya and Lyme disease.
On today's show I am joined by Valneva President and CEO, Thomas Lingelbach to discuss the latest on these vaccine candidates.
7,901 Listeners
77,846 Listeners
2,052 Listeners
452 Listeners
37,360 Listeners
38,374 Listeners
5,283 Listeners
111,917 Listeners
366,047 Listeners
28,216 Listeners
672 Listeners
4 Listeners